Gynecologic Oncology Reports

Gynecologic Oncology Reports

妇科肿瘤报告

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Gynecologic Oncology Reports》是由Elsevier出版社创办的英文国际期刊(ISSN: 2352-5789),该期刊长期致力于妇产科学领域的创新研究,主要研究方向为OBSTETRICS & GYNECOLOGY。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比1%),以发表妇产科学领域等方向的原创性研究为核心(研究类文章占比90.05%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在201篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Gynecologic Oncology Reports审稿周期约为13 Weeks。该刊近年未被列入国际预警名单,年发文量约201篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 201 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
OBSTETRICS & GYNECOLOGY 妇产科学
4区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
OBSTETRICS & GYNECOLOGY 妇产科学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OBSTETRICS & GYNECOLOGY ESCI Q3 97 / 143

32.5

学科:OBSTETRICS & GYNECOLOGY ESCI Q3 103 / 143

28.32

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OBSTETRICS & GYNECOLOGY ESCI Q3 98 / 136

28.3

学科:OBSTETRICS & GYNECOLOGY ESCI Q3 97 / 136

29.04

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:2 SJR:0.457 SNIP:0.626
学科类别 分区 排名 百分位
大类:Medicine 小类:Obstetrics and Gynecology Q3 126 / 218

42%

大类:Medicine 小类:Oncology Q3 294 / 428

31%

期刊发文

  • Laparoscopic radical trachelectomy and pelvic lymphadenectomy without uterine manipulato

    Author: Lin, Shaodan; Huo, Chuying; Lin, Zhongqiu; Lu, Huaiwu

    Journal: GYNECOLOGIC ONCOLOGY REPORTS. 2026; Vol. 64, Issue , pp. -. DOI: 10.1016/j.gore.2026.102034

  • A phase I dose-escalation study of Lobaplatin combined with paclitaxel in platinum-sensitive recurrent ovarian epithelial carcinoma: preliminary safety and tolerability supporting clinical trial dosin

    Author: Zou, Dongling; Gong, Yi; Yang, Yingjie; Ma, Lifang; Yuan, Li; Bai, Jiaying; Zhou, Qi

    Journal: GYNECOLOGIC ONCOLOGY REPORTS. 2026; Vol. 64, Issue , pp. -. DOI: 10.1016/j.gore.2026.102043

  • Patient with HR-proficient advanced ovarian cancer achieved a complete response with Cadonilimab combined chemotherapy (PD-1/CTLA-4 bispecific): a case report and literature revie

    Author: Zhang, Chenge; Dai, Miao; Yang, Jun; Tian, Wenfang; Huang, Si; Bi, Feng; Zheng, Kai; Tang, Jie

    Journal: GYNECOLOGIC ONCOLOGY REPORTS. 2025; Vol. 60, Issue , pp. -. DOI: 10.1016/j.gore.2025.101785

  • Ovotesticular disorders of sex development with dysgerminoma in a 46, XX/46, XY female: A case repor

    Author: Xue, Yafei; Zuo, Shuqi; Cui, Min; Zhao, Xingbo; Qi, Xiaoyi

    Journal: GYNECOLOGIC ONCOLOGY REPORTS. 2025; Vol. 58, Issue , pp. -. DOI: 10.1016/j.gore.2025.101735

  • Vulvar keratoacanthoma may be a malignant precursor: A case report and literature revie

    Author: Chen, Fang; Wang, Yang; Haishaer, Dina; Bai, Feng

    Journal: GYNECOLOGIC ONCOLOGY REPORTS. 2025; Vol. 57, Issue , pp. -. DOI: 10.1016/j.gore.2024.101674

  • Epidemiological study of HPV infection in 24,588 rural women in Luonan, Chin

    Author: Zhao, Xin; Shen, Shi; Su, Cailing; Chang, Juan; Yan, Yunfang; Zhao, Jianmin

    Journal: GYNECOLOGIC ONCOLOGY REPORTS. 2025; Vol. 57, Issue , pp. -. DOI: 10.1016/j.gore.2024.101669